Managing bloodstream infections associated with intravascular catheters

Drug and Therapeutics Bulletin

Volumn 39, Issue 10, 2001, Pages 75-80

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; FLUCLOXACILLIN; FLUCONAZOLE; METICILLIN; MINOCYCLINE; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; SILVER; SULFADIAZINE SILVER; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOOD TRANFUSION; CANDIDA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ADMINISTRATION; ENTEROCOCCUS; FLUID THERAPY; FUNGEMIA; GRAM NEGATIVE BACTERIUM; HEMODIALYSIS; HEMODYNAMIC MONITORING; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; INTRAVASCULAR CATHETER; META ANALYSIS; MORTALITY; PARENTERAL NUTRITION; PATHOGENESIS; PSEUDOMONAS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; UNITED KINGDOM;

EID: 0034749795     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2001.391075     Document Type: Article

References (43)

1. The epic project: Developing national evidence-based guidelines for preventing healthcare associated infections. Phase 1: Guidelines for preventing hospital-acquired infections
2. Catheter-related sepsis: An overview- Part 1
3. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality
4. Consequences of intravascular catheter sepsis
5. Epidemiology of vascular catheter-related bloodstream infections in a large university hospital in Israel
6. Guidelines for the management of intravascular catheter-related infections
7. Guideline for prevention of intravascular device-related infections
8. Nosocomial infection rates in adult and pediatric intensive care units in the United States
9. Diagnosis of central venous catheter related sepsis - A critical look inside
10. Peripherally inserted central catheters in general medicine
11. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients
12. Risk of infection due to central venous catheters: Effect of site of placement and catheter type
13. Tunneling short-term central venous catheters to prevent catheter-related infection: A meta-analysis of randomized controlled trials
14. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients
15. Intravascular catheter associated sepsis: A common problem
16. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections
17. Novel approach to investigate a source of microbial contamination of central venous catheters
18. Rapid diagnosis of central-venous-catheter-related blood stream infection without catheter removal
19. Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy
20. International conference for the development of a consensus on the management and prevention of severe candidal infections
21. Hand hygiene
22. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care
23. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. A meta-analysis
24. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection
25. Two epsiodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter
26. A semiquantitative culture method for identifying intravenous-catheter-related infection
27. Diagnosis of catheter-related bacteraemia: A prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures
28. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia
29. Staphylococcus aureus bacteremia in patients with Hickman catheters
30. Staphylococcus aureus catheter-associated bacteremia
31. Septicaemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: Increasing incidence of catheter-related infections
32. Central venous catheter replacement strategies: A systematic review of the literature
33. Hickman catheter infections in patients with malignancies
34. Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal
35. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis
36. Tackling antimicrobial resistance
37. Management of intravascular catheter-related infections
38. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: A study of 55 cases and review
39. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
40. Antibiotic-lock technique for the treatment of central venous catheter infections
41. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home
42. Intravascular catheter-related infections